Skip to main content

Clinical Trial Management System (CTMS) Market Technology, Size, Growth and Research Report 2020

Clinical Trial Management System (CTMS) Market by Type (Enterprise Clinical Trial Management System), Delivery Model (Licensed Enterprise), Component (Service) and End-User (Medical Device Manufacturers), Trends, Technological scope, Demand, Competitive Share – Global Forecast Till 2023
The Clinical Trial Management System Market keeps the up-to-date contact information of applicants and tracking of deadlines for short-term reports. CTMS also provides a user-friendly structure to assist a business intelligence system and clinicians.
A clinical trial management system (CTMS) is defined as a software system that is used to manage clinical trials in clinical research. Efforts are being made by pharmaceutical companies, hospitals, and clinical centers to manage the clinical trials data.
The Big players in the global clinical trial management system market are – Bioclinica (USA),Bio-Optronics (USA),eClinForce Inc. (USA),Forte Research Systems Inc. (USA),International Business Machines Corporation (IBM) (USA),iWeb Technologies (India),Medidata Solutions (USA),Oracle Corporation (USA),Parexel (USA),and Others.
The rapid increase in the healthcare service benefactors, the increasing role of information technology (IT) in healthcare, and highly accurate information provided by the CTMS are aiding the CTMS market. The most important market driver for the global clinical trial management system market growth is a range of benefits offered by CTMS.
Market Segmentation
The global clinical trial management system market segmentation encompasses component, delivery model, end-user, and type. MRFR’s take on the market marks various facets of the market in-depth.
The component-based segmentation of this market covers services and software. Regarding the delivery model, the market has been segmented into cloud-based CTMS, licensed enterprise, and web-based (Hosted CTMS). Based on the end-user, the market has been segmented into contract research organizations, medical device manufacturers, pharmaceutical & biopharmaceutical companies, and others. By type, the market has been segmented into enterprise clinical trial management system and site clinical trial management system.
The factors that can hinder the market growth include increasing clinical trials failure rates, lengthy clinical trials approval time, and strict government guidelines.
TABLE OF CONTENTS:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Clinical Trial Management System Market, By Type
6.1 Introduction
6.2 Enterprise Clinical Trial Management System
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3 Site Clinical Trial Management System
Continued…
Browse Complete Report Details with list of Tables, Figures and Complete TOC at: https://www.marketresearchfuture.com/reports/clinical-trial-management-system-market-2054
A geographical outlining of the global clinical trial management system market covers the Americas (North America & South America), Asia Pacific, Europe, and the Middle East & Africa (MEA).
LIST OF TABLES
Table 1 Global Clinical trial management system market research Synopsis, 2018–2023
Table 2 Global Clinical trial management system market research Estimates and Forecast, 2018–2023 (USD Million)
Table 3 Global Clinical trial management system Market, by Region, 2018–2023 (USD Million)
Table 4 Global Clinical trial management system Market, by Type, 2018–2023 (USD Million)
Table 5 Global Clinical trial management system Market, by Delivery model, 2018–2023 (USD Million)
Table 6 Global Clinical trial management system Market, by Component, 2018–2023 (USD Million)
Table 7 Global Clinical trial management system Market, by End-users, 2018–2023 (USD Million)
…To be Continued.
Intended audience
  • Pharmaceutical Manufacturers and Suppliers
  • Medical Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Potential Investors
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune – 411028
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...
3 comments
Read more

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...
Post a Comment
Read more

Middle East And Africa Pediatric Healthcare Market Development Research with Forthcoming Opportunities and Challenges

  Middle East And Africa Pediatric Healthcare Market Share, Application And Growth Analysis, By Type Of Diseases (Short Term Diseases, Chronic Diseases And Others), By Therapeutics (Cardiology, Allergy And Immunology, Gastroenterology, Infectious Disease And Others), By Treatment (Medication, Surgery, And Others) - Forecast To 2023 Paediatric Healthcare-Overview Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants (29 days to 2 years), children (2 years to 12 years) and adolescents (12 years to 18 years). Paediatrician is a medical professional who specializes in providing treating the paediatric group. Paediatric medical devices are devices used for the treatment and care of infants and children below 18 years having some healthcare issues. Avail a Free Sample@  https://www.marketresearchfuture.com/...
Post a Comment
Read more